Associated Papers
Pathogenic variation in human DNA damage repair genes was originated from the evolutionary process of modern humans.
Li J et al.
Genes & Diseases, 2026
41624906 (PubMed )
Supplement: mmc1.xlsx › Sheet1
Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.
Zhao B et al.
Bmc Cancer, 2024
38575974 (PubMed )
Supplement: 12885_2024_12160_MOESM6_ESM.xlsx › Sheet1
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
Cobain EF et al.
Jama Oncology, 2021
33630025 (PubMed )
Supplement: jamaoncol-e207987-s006.xlsx › Sheet2
Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
Wendt C et al.
Acta Oncologica (stockholm, Sweden), 2019
Integrative clinical genomics of metastatic cancer.
Robinson DR et al.
Nature, 2017
28783718 (PubMed )
Supplement: NIHMS888166-supplement-Supplementary_Tables.pdf
An inherited NBN mutation is associated with poor prognosis prostate cancer.
Cybulski C et al.
British Journal of Cancer, 2013
Hereditary breast cancer: from molecular pathology to tailored therapies.
Tan DS et al.
Journal of Clinical Pathology, 2008
Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of origin.
Cybulski C
Hereditary Cancer in Clinical Practice, 2007
A novel founder CHEK2 mutation is associated with increased prostate cancer risk.
Cybulski C et al.
Cancer Research, 2004
Select a paper to view details